Maciej Banach: Navigating Therapeutic Complexity in Cardiometabolic Disease Prevention
Maciej Banach, Chief Medical Officer at Graylight Imaging, Visiting Senior Research Fellow at Liverpool Centre for Cardiovascular Science, Adjunct Professor at The Johns Hopkins University School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Progress in Cardiovascular Diseases, adding:
“See our recent paper on a critically important topic: how to deliver effective CVD prevention for patients with multimorbidity and multiple concurrent risk factors, each often requiring several interventions or medications (oral, subcutaneous) with different dosing schedules.
In other words: how can we achieve effective, patient-centered CVD prevention overall after successfully managing individual risk factors?
‘The goal of modern cardiometabolic medicine should be maximal clinical benefit through minimal therapeutic friction (complex regimens, side-effects, monitoring requirements, adherence, high costs, limited access, etc.).
Only by aligning our rapid pace of innovation with the pragmatic constraints of real world care can we ensure that the ‘era of polypharmacy’ leads to better outcomes rather than just more prescriptions.'”
Title: Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies
Authors: Yashendra Sethi, Kunal Mahajan, Michael D. Shapiro, Maciej Banach
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 14:20Javed Anees: The Essentials of aSAH Management
-
Jul 7, 2026, 14:06Christopher Robinson: Early Cytokine Signals in Amniotic Fluid Embolism
-
Jul 7, 2026, 14:06Mohamed Fouad Elsayed Khalil: Comprehensive Guidelines Evidence about Stroke Imaging in Pregnancy
-
Jul 7, 2026, 13:39Abuzar Ghaffari: A Proud ISBT Congress Milestone
-
Jul 7, 2026, 13:24Christoph B. Olivier: New DGK Consensus Recommendations on Switching Antiplatelet Therapies
-
Jul 7, 2026, 13:02Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
-
Jul 7, 2026, 06:19Simone Schoenwaelder: Women Are 25% More Likely to Have Their Stroke Misdiagnosed and Here’s Why
-
Jul 7, 2026, 06:12Dhiraj Bhatia: Extremely Happy to Share Our Review on DNA Nanotechnology in Stroke Repair
-
Jul 7, 2026, 06:04Brian A Beh: An Open Letter to Lisa Murphy Honouring the 30 Years of the Stroke Foundation’s Dedication